We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 326.50
Bid: 325.50
Ask: 326.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.154%)
Open: 326.00
High: 326.50
Low: 323.00
Prev. Close: 326.50
PIN Live PriceLast checked at -
Pantheon International is an Investment Trust

To maximise capital growth by investing in a diversified portfolio of private equity funds and occasionally directly in private companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Refinanced Credit Facility

19 Oct 2023 07:00

RNS Number : 5910Q
Pantheon International PLC
19 October 2023
 

19 October 2023

For immediate release

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, Canada, Australia (other than to persons who are both wholesale clients and professional or sophisticated investors in Australia), Japan, the Republic of South Africa or any other jurisdiction where its release, publication or distribution is or may be unlawful.

Pantheon International Plc

("PIP" or the "Company")

 

Refinanced credit facility with additional flexibility

 

The Company announces that it has agreed a new £500m equivalent multi-tranche, multi-currency revolving credit facility agreement (the "Loan Facility"), which replaces the existing £500m equivalent credit facility and Credit Suisse AG London Branch as a Lender. The new Loan Facility, which is secured by certain assets of the Company, will be split as follows:

 

· Facility A: £400m, expiring in October 2026 with an ongoing option to extend, by agreement, the maturity date by 364 days at a time; and

· Facility B: £100m, expiring in October 2024.

 

The Company has sought to build a long-term, sustainable, more flexible, and diverse capital structure as part of this process, further strengthening the Company's balance sheet. The structure permits Facility A to be increased from £400m to £700m via an uncommitted accordion option, subject to the consent of the participating Lenders, with a covenant package that better supports utilisation under the Loan Facility, the announced tender offer and the ongoing share buyback programme.

 

The new Loan Facility was oversubscribed, with a number of new relationship-focused lenders, State Street Bank & Trust Company, RBS International plc, Mizuho Bank Ltd. and RBC Europe Limited, joining the syndicate alongside two existing relationship lenders, Lloyds Bank Corporate Markets plc and State Street Bank International GmbH. Existing lender, Credit Suisse AG London Branch, will no longer be a lender to the Company. The Loan Facility has been denominated as to US$ 487.7m and ?115.7m to match more closely the principal currencies in which PIP's undrawn commitments are denominated.

 

Depending on the utilisation of the Loan Facility, PIP will pay a commitment fee of between 0.70% and 1.15% per annum on the undrawn portion of the Loan Facility. The rate of interest payable on the drawn portion is the aggregate of the relevant benchmark rate plus 2.95% or 2.25% depending on whether Facility A or B is utilised respectively. The Loan Facility is subject to market standard loan to value and liquidity covenants.

 

PIP's portfolio, which had a weighted average age of 4.8 years as at 31 May 2023, is cash generative. The Company expects to continue to finance its new investments and meet its unfunded commitments principally from cash generated by the Company's portfolio, and also from short-term utilisations under the Loan Facility as PIP optimises its capital structure. As at 19 October 2023, PIP had £125m of drawings under the existing £500m equivalent credit facility which will be refinanced by the new Loan Facility.

 

Commenting on the Loan Facility, John Singer CBE, Chair of PIP, said: "The Board is delighted to have secured the new Loan Facility on competitive terms in the current environment, with a combination of new and existing international relationship-focused lenders. We believe that this demonstrates the quality of PIP's portfolio of private equity investments and the increased flexibility further underpins the strength of PIP's balance sheet."

 

This announcement has been determined to contain inside information for the purposes of the market abuse regulation (EU) No.596/2014 (EU MAR) and of the UK version of EU MAR as it forms part of UK law by virtue of the European Union (Withdrawal) Act (as amended).

 

Ends

 

LEI: 2138001B3CE5S5PEE928

 

For more information, please visit PIP's website at www.piplc.com or contact:

 

Pantheon

Helen Steers / Vicki Bradley

Tel: +44 (0)20 3356 1800

 

Jie Gong

Tel: +852 3718 9605

 

Follow us on LinkedIn: https://www.linkedin.com/company/pantheon-international-plc

 

 

NOTES

 

PIP

PIP is a listed FTSE 250 private equity investment trust, overseen by an independent Board of Directors and managed by Pantheon, one of the leading private equity investment managers globally. PIP offers investors a liquid, differentiated entry point to the excellent growth potential of global private equity, with access to the primary, secondary and co-investment opportunities of many of the best managers in the world. The Company has a track record of NAV outperformance over the long term and manages risk through diversification and rigorous selection based on Pantheon's extensive experience and international platform, and robust investment due diligence and decision-making processes.

 

Pantheon

PIP is managed and advised by Pantheon, a leading global private equity, infrastructure & real assets and private debt investor with 40 years' experience sourcing and executing private market investment opportunities on behalf of clients. Pantheon has $93.4 billion in AUM^^^^ (as at 31 March 2023) and employs approximately 455 staff including 134 investment professionals (as at 30 June 2023) across offices in London, San Francisco, New York, Chicago, Hong Kong, Seoul, Bogotá, Tokyo, Dublin, Berlin and Geneva with representation in a number of other key markets.

 

^^^^This figure includes assets subject to discretionary or non-discretionary management, advice or those limited to a reporting function.

 

 

Important Information

A copy of this announcement will be available on the Company's website at www.piplc.com. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

John Singer CBE

Chair, Pantheon International Plc

Broadwalk House, Southernhay West, Exeter, Devon, EX1 1TS

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFMFWAEDSELS
Date   Source Headline
1st May 20249:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:01 amRNSMonthly Performance Update
26th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20243:52 pmRNSInvestor Presentation
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20245:35 pmRNSHolding(s) in Company
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202412:24 pmRNSHolding(s) in Company
2nd Apr 202412:03 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSMonthly Performance Update
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 202412:43 pmRNSHolding(s) in Company
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 202410:55 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:01 amRNSMonthly Performance Update
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20242:42 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:02 amRNSHalf-year Report
22nd Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 202412:59 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSMonthly Performance Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.